ARTICLE | Company News
Metabasis, Cengent deal
July 3, 2006 7:00 AM UTC
MBRX acquired a protein tyrosine phosphatase 1B ( PTP-1B) program for metabolic diseases from note holders of Cengent (San Diego, Calif.). The program includes several lead compounds and compound lib...